Jobs A, Stiermaier T, Klotz S, Eitel I
Medizinische Klinik II, Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
Klinik für Herz- und thorakale Gefäßchirurgie, Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland.
Herz. 2018 Feb;43(1):26-33. doi: 10.1007/s00059-017-4646-2.
At the end of August 2017 the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) published new joint guidelines for the treatment of valvular heart disease. These guidelines incorporate the scientific progress since the last version of the guidelines published in 2012. This article reviews current guideline recommendations for antiplatelet and anticoagulative therapy after surgical/interventional treatment of the aortic and mitral valves and discusses the underlying scientific evidence.
2017年8月底，欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）发布了瓣膜性心脏病治疗的新联合指南。这些指南纳入了自2012年发布上一版指南以来的科学进展。本文回顾了主动脉瓣和二尖瓣手术/介入治疗后抗血小板和抗凝治疗的当前指南建议，并讨论了其潜在的科学证据。
